Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 May 1;163(5):1191-202.
doi: 10.1084/jem.163.5.1191.

Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein

J B Dale, E H Beachey

Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein

J B Dale et al. J Exp Med. .

Abstract

We have used a set of overlapping chemically synthesized peptides representing the amino terminus of type 5 streptococcal M protein to localize protective, as opposed to nonprotective and tissue-crossreactive epitopes that might be appropriate for vaccine formulations. Rabbit antisera raised against SM5(1-35) reacted in high titer with pep M5 by ELISA and opsonized type 5 streptococci. None of the antisera crossreacted with human heart tissue or myosin. Antisera against SM5(26-35) reacted with SM5(1-35) and pep M5 but failed to opsonize type 5 streptococci. Particle-phase ELISA indicated that SM5(26-35) antibodies were directed against nonprotective determinants of pep M5 that were not exposed on the surface of viable organisms. Opsonization and ELISA inhibition assays showed that, of the SM5(1-35) antibodies that reacted with M5, all were inhibited by SM5(14-35), whereas none was inhibited by SM5(26-35), suggesting that the protective epitopes of SM5(1-35) resided between residues 14 and 26. This was confirmed by subsequent chemical synthesis of this region; SM5(14-26) totally inhibited SM5(1-35) antibodies that reacted with pep M5 in ELISA, and completely inhibited opsonization of type 5 streptococci by SM5(1-35) antibodies. SM5(14-26) evoked high titers of type-specific, opsonic antibodies against type 5 streptococci, confirming the protective immunogenicity of this 13-residue peptide of type 5 M protein.

PubMed Disclaimer

References

    1. J Exp Med. 1983 Nov 1;158(5):1727-32 - PubMed
    1. J Biol Chem. 1983 Nov 10;258(21):13250-7 - PubMed
    1. Proc Natl Acad Sci U S A. 1984 Apr;81(7):2203-7 - PubMed
    1. J Exp Med. 1984 Jul 1;160(1):208-21 - PubMed
    1. Infect Immun. 1984 Oct;46(1):267-9 - PubMed

Publication types